On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

One of the UK’s most senior radiotherapy experts has been diagnosed with incurable cancer – and said it was “bizarrely ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

There seems to be no association between hormone therapy (HT) and glioma risk among US women, according to a study published online.

Felix Y. Feng, MD Under his guidance, biologists and computational scientists in the Feng Laboratory at UCSF produced the first clinical-grade biomarker panels that predict prostate cancer response to ...

were unsuitable to receive more hormonal therapy, and had already received one or two rounds of chemotherapy for advanced or metastatic cancer. Patients were randomly assigned to receive either ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...

A pioneering cancer survivor from Andover has hailed a revolutionary treatment for its life-changing benefits. Joe Tuftnell, 80, was one of the first Brits to undergo proton beam therapy for prostate ...

It has shown promising results in treating metastatic castration-resistant prostate cancer ... responds to hormonal treatments. Patients looking to explore this cutting-edge therapy can get ...